Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Chinese (SSE) Clinical Research and Equipment Industry Analysis

UpdatedJun 15, 2026
DataAggregated Company Financials
Companies27
  • 7D1.5%
  • 3M-2.6%
  • 1Y19.9%
  • YTDn/a

In the last week, the Clinical Research and Equipment industry is up 1.5%, with WuXi AppTec up 3.5%. Meanwhile, Shanghai Runda Medical Technology actually underperformed within the industry, shrinking 6.1% in the last week. In the last 12 months, the industry was up 20%. Looking forward, earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the Chinese Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 16 Jun 2026CN¥538.4bCN¥98.8bCN¥21.9b48.2x24.6x5.4x
Thu, 14 May 2026CN¥607.8bCN¥98.7bCN¥21.7b58.5x28x6.2x
Sat, 11 Apr 2026CN¥613.8bCN¥94.9bCN¥20.7b64.5x29.6x6.5x
Mon, 09 Mar 2026CN¥559.9bCN¥94.5bCN¥18.7b60x30x5.9x
Wed, 04 Feb 2026CN¥589.3bCN¥94.3bCN¥18.5b64.3x31.8x6.2x
Fri, 02 Jan 2026CN¥546.6bCN¥94.3bCN¥18.5b59.6x29.5x5.8x
Sun, 30 Nov 2025CN¥549.3bCN¥94.3bCN¥18.5b65.6x29.6x5.8x
Tue, 28 Oct 2025CN¥610.2bCN¥94.0bCN¥18.6b70.2x32.8x6.5x
Thu, 25 Sep 2025CN¥618.9bCN¥92.1bCN¥17.4b72.5x35.5x6.7x
Sat, 23 Aug 2025CN¥585.9bCN¥92.5bCN¥17.5b61.4x33.4x6.3x
Mon, 21 Jul 2025CN¥513.3bCN¥89.8bCN¥15.4b53x33.4x5.7x
Wed, 18 Jun 2025CN¥429.2bCN¥89.8bCN¥15.4b47.4x27.9x4.8x
Fri, 16 May 2025CN¥393.2bCN¥89.2bCN¥15.1b46.1x26.1x4.4x
Sun, 13 Apr 2025CN¥367.7bCN¥88.5bCN¥14.0b38.3x26.2x4.2x
Tue, 11 Mar 2025CN¥434.9bCN¥89.0bCN¥11.3b44.2x38.4x4.9x
Thu, 06 Feb 2025CN¥366.9bCN¥88.1bCN¥11.2b38.6x32.6x4.2x
Sat, 04 Jan 2025CN¥347.0bCN¥87.8bCN¥11.2b34.2x31x4x
Mon, 02 Dec 2024CN¥366.7bCN¥87.8bCN¥11.2b38.8x32.8x4.2x
Wed, 30 Oct 2024CN¥383.5bCN¥88.1bCN¥11.7b35.6x32.6x4.4x
Fri, 27 Sep 2024CN¥303.7bCN¥88.2bCN¥12.4b28.9x24.5x3.4x
Sun, 25 Aug 2024CN¥262.3bCN¥87.4bCN¥12.3b23.8x21.3x3x
Tue, 23 Jul 2024CN¥289.8bCN¥88.3bCN¥13.4b27.6x21.6x3.3x
Thu, 20 Jun 2024CN¥298.0bCN¥88.3bCN¥13.4b26.1x22.3x3.4x
Sat, 18 May 2024CN¥330.4bCN¥88.3bCN¥13.3b29.1x24.8x3.7x
Mon, 15 Apr 2024CN¥321.2bCN¥90.3bCN¥15.0b32.4x21.4x3.6x
Wed, 13 Mar 2024CN¥374.2bCN¥90.5bCN¥15.5b33.5x24.1x4.1x
Fri, 09 Feb 2024CN¥349.2bCN¥91.1bCN¥16.1b29.9x21.7x3.8x
Sun, 07 Jan 2024CN¥448.6bCN¥91.1bCN¥16.1b37.1x27.9x4.9x
Tue, 05 Dec 2023CN¥503.9bCN¥91.1bCN¥16.1b37.3x31.3x5.5x
Thu, 02 Nov 2023CN¥530.5bCN¥91.0bCN¥16.3b37.8x32.6x5.8x
Sat, 30 Sep 2023CN¥520.4bCN¥92.0bCN¥18.3b35.6x28.4x5.7x
Mon, 28 Aug 2023CN¥484.4bCN¥91.8bCN¥18.7b35x25.9x5.3x
Wed, 26 Jul 2023CN¥464.2bCN¥91.3bCN¥18.5b35.5x25.1x5.1x
Fri, 23 Jun 2023CN¥455.6bCN¥91.3bCN¥18.5b33.9x24.7x5x
Price to Earnings Ratio

24.7x


Total Market Cap: CN¥455.6bTotal Earnings: CN¥18.5bTotal Revenue: CN¥91.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Clinical Research and Equipment Industry Price to Earnings3Y Average 28.6x202420252026
Current Industry PE
  • Investors are pessimistic on the Chinese Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.6x which is lower than its 3-year average PE of 28.7x.
  • The industry is trading close to its 3-year average PS ratio of 5.0x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have grown 5.8% per year over the last three years.
  • Revenues for these companies have grown 2.7% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Chinese Clinical Research and Equipment compare with similar industries?

CN Market-1.46%
Healthcare-0.41%
Life Sciences1.46%
Clinical Research and Equipment1.46%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
603259 WuXi AppTecCN¥99.373.5%
+CN¥10.0b		45.2%PE15.7x
300347 Hangzhou Tigermed ConsultingCN¥39.408.9%
+CN¥2.8b		-23.9%PE43.7x
688758 Suzhou Sepax TechnologiesCN¥20.2822.2%
+CN¥1.5b		26.1%PE61.1x
688131 Shanghai Haoyuan ChemexpressCN¥75.927.1%
+CN¥1.1b		63.0%PE65.7x
603127 Joinn Laboratories(China)Co.LtdCN¥32.744.4%
+CN¥1.0b		61.9%PE48.5x

Latest News

688114
CN¥49.43
MGI Tech
7D
4.7%
1Y
-25.0%
688758
CN¥20.28
Suzhou Sepax Technologies
7D
22.2%
1Y
26.1%
688238
CN¥5.38
Shanghai Obio Technology (Group)
7D
-1.5%
1Y
-11.1%
300404
CN¥8.42
Boji Medical TechnologyLtd
7D
-3.1%
1Y
-8.5%
603127
CN¥32.74
Joinn Laboratories(China)Co.Ltd
7D
4.4%
1Y
61.9%
300030
CN¥6.40
Improve Medical Instruments
7D
-2.0%
1Y
-2.3%
688621
CN¥52.65
Beijing Sun-Novo Pharmaceutical Research
7D
9.8%
1Y
5.8%
688315
CN¥12.31
Novogene
7D
-4.8%
1Y
-8.5%
300347
CN¥39.40
Hangzhou Tigermed Consulting
7D
8.9%
1Y
-23.9%
603259
CN¥99.37
WuXi AppTec
7D
3.5%
1Y
45.2%
Narrative Update • Jun 01

603259: Conviction List Inclusion And Buybacks Are Expected To Support Future Earnings

Analysts have raised their price target for WuXi AppTec from CN¥152.00 to about CN¥169.13, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. This shift aligns with recent positive Street research attention, including the stock being added to a major APAC conviction list.
300759
CN¥22.47
Pharmaron Beijing
7D
1.6%
1Y
-9.0%
301096
CN¥56.62
Hangzhou Bio-Sincerity Pharma-TechLtd
7D
-1.1%
1Y
26.8%
300463
CN¥8.65
Maccura BiotechnologyLtd
7D
-1.6%
1Y
-25.9%
603108
CN¥10.55
Shanghai Runda Medical Technology
7D
-6.1%
1Y
-38.9%
688755
CN¥25.48
Jiangsu Hanbon Science and Technology
7D
-1.4%
1Y
-29.1%
688131
CN¥75.92
Shanghai Haoyuan Chemexpress
7D
7.1%
1Y
63.0%